Cystic Fibrosis: Early CF Airway Disease Markers
A study, published in the Journal of Cystic Fibrosis, looks at early markers of cystic fibrosis.
A study, published in the Journal of Cystic Fibrosis, looks at early markers of cystic fibrosis.
While rapid antigen COVID tests remain a useful tool for the detection of COVID-19 infections, continuous assessment and updating is likely needed in the context of variants of concern.
The global COPD burden could be significantly reduced in low and middle-income countries by assessing patients via questionnaire and peak expiratory flow device, according to an international study published in JAMA.
The US FDA updated the medical device shortage list to include all blood specimen collection tubes to the testing supplies and equipment – specimen collection category.
Read MorePathogenomix Inc’s Patho-Seq is designed for the rapid detection and identification of bacteria for a broad list of clinical conditions and sample types, including sepsis from whole blood samples and bacterial meningitis from CSF.
Read MoreMild symptoms, poor knowledge of nearby testing sites, and certain demographic factors have been identified as barriers to COVID-19 testing.
Read MoreBronchoscopy plays a role in both diagnosis and treatment of lung disease and recent advances in the procedure have greatly enhanced the usefulness of the fiberoptic bronchoscope.
Read MoreThe FDA has warned consumers to stop using the LuSys Laboratories COVID-19 Antigen Test (Nasal/Saliva) and the LuSys Laboratories COVID-19 IgG/IgM Antibody Test.
Read MoreThe earliest batch of COVID-19 tests distributed by the US CDC exhibited false positive reactivity of negative controls due to flaws in assay design and contamination in one of the assay components, according to a CDC internal investigation.
Read MoreWerfen has received FDA 510(k) clearance for its GEM Hemochron 100 whole blood hemostasis system, which will be commercialized in the US in early 2022.
Read MoreThe successful implementation of transcutaneous CO2 equipment at Hershey Medical Center’s Level IV NICU demonstrates that the technology has evolved to accommodate the diagnostic monitoring needs of neonatal care providers and patients, according to this case study by clinicians in the center’s NICU.
Read MoreThe FDA has issued an emergency use authorization for the Acon Laboratories Flowflex COVID-19 Home Test, an over-the-counter COVID-19 antigen test.
Read MoreParadoxical bronchospasm can represent a rare unrecognized phenotype of patients with COPD and asthma and should be readily recognized and reported, a new study presented at Chest 2021 reports.
Read MoreThe tools and best practices for handling infection control during pulmonary function testing have evolved and changed for the better during the pandemic.
Read MoreThe levels of two cytokines found in saliva were higher in children with severe COVID-19 compared to kids without severe infection.
Read More